Hanzol, Hazel J.
HRN: 02-24-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/01/2024
CEFUROXIME 500MG (TAB)
01/01/2024
01/07/2024
ORAL
500mg
BID
NSVD With Perineal Laceration
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes